| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42747-304-01 | 42747-304 | HUMAN PRESCRIPTION DRUG | CRYSVITA | Burosumab | INJECTION | SUBCUTANEOUS | 20230901 | N/A | BLA | BLA761068 | Kyowa Kirin, Inc. | BUROSUMAB | 30 mg/mL | 1 mL in 1 VIAL, SINGLE-USE (42747-304-01) |
| 42747-203-01 | 42747-203 | HUMAN PRESCRIPTION DRUG | CRYSVITA | Burosumab | INJECTION | SUBCUTANEOUS | 20230901 | N/A | BLA | BLA761068 | Kyowa Kirin, Inc. | BUROSUMAB | 20 mg/mL | 1 mL in 1 VIAL, SINGLE-USE (42747-203-01) |
| 42747-102-01 | 42747-102 | HUMAN PRESCRIPTION DRUG | CRYSVITA | Burosumab | INJECTION | SUBCUTANEOUS | 20230901 | N/A | BLA | BLA761068 | Kyowa Kirin, Inc. | BUROSUMAB | 10 mg/mL | 1 mL in 1 VIAL, SINGLE-USE (42747-102-01) |